Hestia Insight (Hestia Insight) Short-Term Debt : $0.05 Mil (As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Hestia Insight Short-Term Debt?

Hestia Insight's Short-Term Debt for the quarter that ended in Feb. 2024 was $0.05 Mil.

Hestia Insight's quarterly Short-Term Debt stayed the same from Aug. 2023 ($0.00 Mil) to Nov. 2023 ($0.00 Mil) but then increased from Nov. 2023 ($0.00 Mil) to Feb. 2024 ($0.05 Mil).

Hestia Insight Short-Term Debt Historical Data

The historical data trend for Hestia Insight's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hestia Insight Short-Term Debt Chart

Hestia Insight Annual Data

Trend

Nov22

Nov23

Short-Term Debt

Hestia Insight Quarterly Data
	Feb22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
Short-Term Debt	Get a 7-Day Free Trial			-	-	-	-	0.05

Hestia Insight Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Hestia Insight Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Hestia Insight's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hestia Insight (Hestia Insight) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Hestia Insight Inc (OTCPK:HSTA) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 S. 4th Street, Suite 500, Las Vegas, NV, USA, 89101

Website

http://www.hestiainsight.com

Hestia Insight Inc provides strategic consulting and capital market advisory services for micro, small and medium-sized companies in the healthcare, biotech and fintech sectors. It also provides access to seed capital and mezzanine funding for qualified emerging companies in these industries. The firm derives all of its revenue from consulting services.